Effect of tolvaptan on long-term prognosis in Japanese patients with heart failure: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.1027
Abstract: Tolvaptan (TLV), a vasopressin antagonist, can promote water diuresis and overcome various disadvantages associated with conventional diuretics by ameliorating congestive symptoms and improving hyponatremia while maintaining haemodynamics and renal function. Large-scale clinical trials conducted primarily… read more here.
Keywords: add therapy; long term; prognosis; tlv add ... See more keywords